UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $15.73, for a total transaction of $707,850.00. Following the completion of the transaction, the chief executive officer owned 28,343,585 shares of the company’s stock, valued at $445,844,592.05. This trade represents a 0.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Wednesday, January 7th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $17.32, for a total value of $779,400.00.
- On Friday, January 2nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.38, for a total value of $737,100.00.
- On Wednesday, December 31st, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.55, for a total value of $744,750.00.
- On Monday, December 29th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.44, for a total value of $739,800.00.
- On Friday, December 26th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.90, for a total value of $760,500.00.
- On Wednesday, December 24th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.91, for a total transaction of $760,950.00.
- On Monday, December 22nd, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.49, for a total transaction of $742,050.00.
- On Friday, December 19th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $16.07, for a total value of $723,150.00.
- On Wednesday, December 17th, Daniel Dines sold 45,000 shares of UiPath stock. The stock was sold at an average price of $16.11, for a total value of $724,950.00.
- On Monday, December 15th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $17.30, for a total transaction of $778,500.00.
UiPath Stock Up 2.7%
Shares of NYSE PATH opened at $17.81 on Thursday. UiPath, Inc. has a twelve month low of $9.38 and a twelve month high of $19.84. The stock has a market cap of $9.52 billion, a price-to-earnings ratio of 42.39, a P/E/G ratio of 5.08 and a beta of 1.08. The company’s fifty day moving average is $15.61 and its 200-day moving average is $13.75.
Key Headlines Impacting UiPath
Here are the key news stories impacting UiPath this week:
- Positive Sentiment: Analyst/industry write-ups are bullish on UiPath’s role in the AI and robotics wave, which can attract growth/AI-focused fund flows and improve sentiment. Top Robotics Stocks That Could Drive Impressive Returns in 2026
- Positive Sentiment: Zacks also lists PATH among small-/mid-cap AI stocks that could outperform in 2026, reinforcing the growth narrative for revenue multiple expansion. Buy These 5 Small and Mid-Sized AI Stocks for Stellar Returns in 2026
- Positive Sentiment: Product/partnership momentum: UiPath and Talkdesk announced a collaboration to transform customer experience journeys — a commercial win that supports enterprise adoption. UiPath and Talkdesk collaborate to transform customer experience journeys
- Positive Sentiment: Coverage showing UiPath’s agentic AI tested in regulated industries supports product relevance and potential larger enterprise deployments. Evergen and UiPath show how agentic AI tests process discipline in regulated industries
- Neutral Sentiment: UiPath will present at the Needham Growth Conference (Jan 13); this offers investor access and a chance for management to refresh guidance but is informational until new guidance/data are given. UiPath to Participate in the 28th Annual Needham Growth Conference
- Neutral Sentiment: Valuation/coverage pieces (Yahoo/AAII/Benzinga) are debating whether PATH is attractively priced after recent moves — helpful for positioning but not immediate catalysts. UiPath (PATH) Valuation Check After CEO Share Sales And S&P MidCap 400 Inclusion
- Negative Sentiment: Significant insider selling: CFO Ashim Gupta sold 67,468 shares (~10.8% reduction of his holding) and CEO Daniel Dines sold multiple 45,000-share blocks in recent days. Large, disclosed insider sales and a repeated selling pattern from the CEO are likely dragging on sentiment and are a primary near-term negative factor. SEC filing: Gupta sale
- Negative Sentiment: RBC cut its PATH price target (reported coverage), signaling more cautious near-term upside and giving traders a concrete downtick in expectations. UiPath price target lowered to $17 from $19 at RBC Capital
Institutional Investors Weigh In On UiPath
Hedge funds have recently bought and sold shares of the company. Noble Wealth Management PBC bought a new stake in UiPath in the fourth quarter valued at approximately $25,000. Twin Peaks Wealth Advisors LLC acquired a new position in shares of UiPath during the 2nd quarter worth approximately $28,000. AdvisorNet Financial Inc increased its holdings in shares of UiPath by 320.4% during the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock worth $32,000 after acquiring an additional 1,887 shares during the last quarter. GAMMA Investing LLC raised its stake in UiPath by 48.0% in the 2nd quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock valued at $38,000 after acquiring an additional 969 shares during the period. Finally, IFP Advisors Inc lifted its holdings in UiPath by 508.0% during the 2nd quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock valued at $42,000 after purchasing an additional 2,743 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts recently commented on PATH shares. Canaccord Genuity Group increased their target price on shares of UiPath from $15.00 to $19.00 and gave the stock a “buy” rating in a report on Thursday, December 4th. Mizuho increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock a “neutral” rating in a research note on Thursday, December 4th. Morgan Stanley raised their price objective on UiPath from $15.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, December 9th. Truist Financial set a $17.00 target price on UiPath in a report on Thursday, December 4th. Finally, Wall Street Zen cut UiPath from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 6th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, UiPath currently has a consensus rating of “Hold” and a consensus target price of $15.85.
View Our Latest Stock Analysis on UiPath
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
See Also
- Five stocks we like better than UiPath
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
- ALERT: Drop these 5 stocks before January 2026!
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
